Rongfang He

1.1k total citations · 1 hit paper
42 papers, 859 citations indexed

About

Rongfang He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rongfang He has authored 42 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Rongfang He's work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (9 papers) and MicroRNA in disease regulation (8 papers). Rongfang He is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (9 papers) and MicroRNA in disease regulation (8 papers). Rongfang He collaborates with scholars based in China and United States. Rongfang He's co-authors include Hailin Tang, Xiaoming Xie, Qianjin Liao, Yujuan Zhou, Xiaoling Li, Zhaoyang Zeng, Guiyuan Li, Peng Liu, Wei Xiong and Yuehua Li and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Microbiology and Journal of Affective Disorders.

In The Last Decade

Rongfang He

38 papers receiving 853 citations

Hit Papers

Methylation of GPRC5A promotes liver metastasis and docet... 2024 2026 2024 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
    2024 106 citations Yeru Tan, Jindong Xie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongfang He China 15 651 540 104 99 62 42 859
Aijun Zhou China 11 739 1.1× 558 1.0× 91 0.9× 169 1.7× 101 1.6× 20 962
Chen Luo China 15 319 0.5× 202 0.4× 97 0.9× 103 1.0× 65 1.0× 39 553
Tiankun Lu China 10 519 0.8× 337 0.6× 45 0.4× 134 1.4× 111 1.8× 10 729
Haitao Wang China 17 459 0.7× 342 0.6× 76 0.7× 61 0.6× 24 0.4× 38 698
Wan Li China 14 358 0.5× 155 0.3× 75 0.7× 104 1.1× 74 1.2× 16 625
Je Yeong Ko South Korea 15 544 0.8× 250 0.5× 39 0.4× 107 1.1× 53 0.9× 38 749
Yulan Zhu China 18 463 0.7× 316 0.6× 77 0.7× 147 1.5× 76 1.2× 30 753
Zheng Lü China 14 339 0.5× 160 0.3× 64 0.6× 98 1.0× 32 0.5× 58 669

Countries citing papers authored by Rongfang He

Since Specialization
Citations

This map shows the geographic impact of Rongfang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongfang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongfang He more than expected).

Fields of papers citing papers by Rongfang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongfang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongfang He. The network helps show where Rongfang He may publish in the future.

Co-authorship network of co-authors of Rongfang He

This figure shows the co-authorship network connecting the top 25 collaborators of Rongfang He. A scholar is included among the top collaborators of Rongfang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongfang He. Rongfang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fu, Guang, Xiguang Chen, Rongfang He, et al.. (2025). Integrated single-nuclear RNA sequencing analysis reveals distinct characteristics of mucinous adenocarcinoma in right-sided colon cancer. International Journal of Biological Macromolecules. 309(Pt 1). 142744–142744.
3.
Liang, Yuxin, Pei Li, Rongfang He, et al.. (2025). DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC. Molecular Therapy. 34(2). 985–1008. 1 indexed citations
4.
Yang, Fang, et al.. (2024). Causal associations between human gut microbiota and hemorrhoidal disease: A two-sample Mendelian randomization study. Medicine. 103(13). e37599–e37599. 1 indexed citations
5.
Huang, Min, et al.. (2023). COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study. Human Vaccines & Immunotherapeutics. 19(1). 2166323–2166323. 3 indexed citations
6.
7.
8.
Li, Yuehua, Lijun Zeng, Wenjie Feng, et al.. (2023). Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation. Environmental Research. 239(Pt 1). 117266–117266. 11 indexed citations
9.
Yu, Hua, Xuemei Liang, Chaohua Huang, et al.. (2022). Altered spontaneous brain activity in major depressive disorder: An activation likelihood estimation meta-analysis. Journal of Affective Disorders. 314. 19–26. 20 indexed citations
10.
Yu, Jia, Rongfang He, Xiaoyan Yang, et al.. (2022). LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis. Disease Markers. 2022. 1–16. 5 indexed citations
11.
Feng, Wenjie, Hongbo Zhu, Yeru Tan, et al.. (2022). Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer. Frontiers in Immunology. 13. 1038225–1038225. 28 indexed citations
12.
Shao, Ruonan, et al.. (2022). Comprehensive analysis of a pyroptosis-related gene signature of clinical and biological value in acute myeloid leukaemia. International Immunopharmacology. 108. 108802–108802. 3 indexed citations
13.
Tian, W. H., Chao Zhang, Jindong Xie, et al.. (2022). Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature. Frontiers in Immunology. 13. 1056680–1056680. 15 indexed citations
14.
Xiao, Shuai, Jia Huang, Yiwei Zhang, et al.. (2021). Endoscopy biopsy is not efficiency enough for diagnosis of mucinous colorectal adenocarcinoma. Discover Oncology. 12(1). 2 indexed citations
15.
Zhu, Hongbo, Ting Gao, Yu Zhou, et al.. (2021). The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer. Frontiers in Oncology. 11. 605988–605988. 17 indexed citations
16.
He, Rongfang, Juan Zhang, & Dan Luo. (2020). Acacetin alleviates myocardial fibrosis via TGF-β1/Smad3 signaling pathway. Journal of Molecular and Cellular Cardiology. 140. 42–43. 1 indexed citations
17.
Tang, Hailin, Bo Chen, Peng Liu, et al.. (2019). SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer. Carcinogenesis. 40(10). 1278–1287. 32 indexed citations
18.
He, Rongfang, et al.. (2018). New Insights Into Interactions of Presynaptic Calcium Channel Subtypes and SNARE Proteins in Neurotransmitter Release. Frontiers in Molecular Neuroscience. 11. 213–213. 21 indexed citations
19.
Xie, Liming, Rongfang He, Zhiwei Zhang, Yunyun Tang, & Zhaoyang Luo. (2013). [miR-124 suppresses cell proliferation and invasion in gastric carcinoma and its mechanism].. PubMed. 35(7). 497–500. 3 indexed citations
20.
Tang, Yunlian, Rongfang He, Yang Zhang, et al.. (2011). Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras. Virology Journal. 8(1). 213–213. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aijun Zhou Breakdown of academic impact, for papers by Chen Luo Breakdown of academic impact, for papers by Tiankun Lu Breakdown of academic impact, for papers by Haitao Wang Breakdown of academic impact, for papers by Wan Li Breakdown of academic impact, for papers by Je Yeong Ko Breakdown of academic impact, for papers by Yulan Zhu Breakdown of academic impact, for papers by Zheng Lü
Rankless by CCL
2026